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Rumination Syndrome in Children
and Adolescents: A Mini Review
Marc Martinez 1 , Sandeep Rathod 1 , Hunter J. Friesen 2 , John M. Rosen 3,4 ,
Craig A. Friesen 3,4* and Jennifer V. Schurman 3,4
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Medicine, Kansas City, MO, United States, 3 Division of Gastroenteology, Hepatology, and Nutrition, Children’s Mercy Kansas
City, Kansas City, MO, United States, 4 Department of Pediatrics, University of Missouri Kansas City School of Medicine,
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Introduction: Rumination syndrome involves recurrent regurgitation of food and is
believed to be underdiagnosed with patients experiencing long delays in diagnosis. It can
be associated with significant social consequences, high rates of school absenteeism,
and medical complications such as weight loss. The primary aims of the current
review are to assess the literature regarding prevalence, pathophysiology, and treatment
outcomes with a focus on neurotypical children and adolescents.
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Results: Population studies in children/adolescents, 5 years of age or older, range
from 0 to 5.1%. There are fewer studies in clinical settings, but the prevalence
appears to be higher in patients with other gastrointestinal symptoms, particularly
chronic vomiting. While physiologic changes that occur during a rumination episode are
well-described, the underlying cause is less well-defined. In general, rumination appears
to have similarities to other functional gastrointestinal disorders including dysmotility,
possibly inflammation, and an interaction with psychologic function. While diaphragmatic
breathing is considered the mainstay of treatment, pediatric data demonstrating efficacy
is lacking, especially as an isolated treatment.
Conclusion: Pediatric rumination syndrome remains greatly understudied, particularly
regarding treatment. There is a need to better define prevalence in both the primary
care and subspecialty clinical settings, especially in patients presenting with vomiting
or apparent gastroesophageal reflux. There is a need to determine whether treatment
of co-morbid conditions results in improvement of rumination. Diaphragmatic breathing
needs to be studied and compared to other competing responses.
Keywords: rumination syndrome, regurgitation, vomiting, gastroesophageal reflux, functional gastrointestinal
disorders, diaphragmatic breathing, motility

INTRODUCTION
Rumination syndrome in children and adolescents is defined by Rome IV criteria as repeated
regurgitation with rechewing or expulsion of food that begins shortly after meal ingestion, does not
occur at night, and is not preceded by retching (1). While rumination can occur in any youth, three
different groups have been the focus of research: infants/toddlers, neurodiverse youth (e.g., those
with psychiatric, neurologic, or developmental disorders), and neurotypical youth (2, 3). Etiologies
and treatments vary significantly by group. The focus of the current article is neurotypical children
and adolescents.
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to pathophysiology, and 5 related to treatment in pediatric
rumination syndrome.

Rumination is believed to be underdiagnosed, with patients
seeing numerous providers and experiencing long delays before
diagnosis (4, 5). Patients are frequently believed to have
refractory gastro-esophageal reflux (6). Rumination also is
frequently associated with other gastrointestinal symptoms—
including abdominal pain, nausea, constipation, and diarrhea—
which may become the focus of evaluation (5, 7). While the
diagnosis of rumination does not require testing, evaluations
such as endoscopy, gastric emptying studies, and pH studies
are frequently undertaken to evaluate regurgitation (5, 8). While
abnormal tests are not uncommon, it is unknown whether
abnormal tests are clinically important or identify factors
important to generation of rumination. In addition, rumination
itself may result in abnormal test results such as an abnormal pH
or impedance study generated by frequent rumination.
Rumination is generally believed to be “benign” from the
standpoint of physical complications. However, rumination can
be associated with significant social consequences, including high
rates of school absenteeism, and medical complications have
been reported, including dental erosions (5, 7, 9). Rumination
syndrome in youth also has been associated with weight loss in
17–43% (5, 7).
This article represents a review of the most current
information on rumination syndrome in neurotypical youth
(those without co-morbid neurologic or developmental
disorders), particularly prevalence, pathophysiology, and
treatment outcomes.

Prevalence
Most prevalence estimates have resulted from general population
studies, often performed in schools [(10–27); see Table 1].
Estimates are available from countries in North America, South
America, Europe, and Asia. Overall, prevalence ranges from 0
to 9.7% with a tendency to be higher in children 4 years of age
or younger when studies assess across wide pediatric age ranges.
The prevalence in youth 5 years of age or older range from 0
to 5.1%. In these older children and adolescents, the highest
prevalence has been reported in two studies in Sri Lanka and
one from the United States (18, 23, 27). Outside Sri Lanka, other
studies in Asian countries report low prevalence, as do studies
of older children in South America (14, 19, 21, 22, 25). All but
two of the 18 prevalence studies have utilized the Questionnaire
on Pediatric Gastrointestinal Symptoms (QPGS; usually the
Rome III version) or the closely related Rome IV Diagnostic
Questionnaire. Most often, a translated version of the QPGS was
utilized although it is often unclear whether the translated version
had been validated. Most studies evaluated prevalence across
all pediatric functional gastrointestinal disorders, including
reporting of rumination syndrome prevalence data under this
broader umbrella. Two studies utilized the Eating Disturbances
in Youth Questionnaire (EDY-Q) and assessed specifically for
rumination and pica (16, 20). These two studies generally tended
to report higher prevalence. Only one study utilized Rome IV
criteria, also reporting prevalence by Rome III criteria (21).
As compared to Rome III criteria, Rome IV eliminated the
requirement that rumination be painless and also unresponsive
to treatment directed at gastroesophageal reflux. In this study,
rumination prevalence was very similar between the two criteria
(0.5 vs. 0.4%) (21).
While there are a relatively large number of general population
studies, there are very few studies performed in a clinical
setting, particularly in older children and adolescents. Malik and
colleagues diagnosed rumination in 30 of 50 patients presenting
to a pediatric gastroenterology for a primary complaint of
vomiting (7). In two studies, older youth tended to report
prevalence on the higher end when assessed in a pediatric
gastroenterology clinic (3.5%; United States) or for a recurrent
abdominal pain in a general outpatient clinic (2%; Norway) (26,
27). This gastroenterology clinic study also compared prevalence
based on parent report as compared to self-report in youth 10
years of age or older and found a >4-fold higher prevalence
by self-report (3.5 vs. 0.8%) (27). Utilizing the QPGS, we have
previously shown a discordance in diagnosis between parent
and child report across abdominal pain-associated functional
gastrointestinal disorders (FGIDs); this may hold true for
rumination, as well, but further evaluation is needed (28).
While the prevalence of rumination has been studied in general
populations, given the high variability from study-to-study, it
is unclear whether the methodology is sufficient to identify all
patients with rumination. More studies specifically assessing
rumination in the general population are needed. Additionally,
more studies are needed to understand the prevalence in a

Search Strategy and Selection Criteria
With the assistance of a medical librarian from the Children’s
Mercy Kansas City, we conducted a systematic search of the
literature. Following the PRISMA checklist, we queried five
electronic databases: PubMed, Embase, CINAHL, Cochrane
CENTRAL, and Scopus from January 1, 2000 to June 30, 2020.
Our search strategy centered on Medical Subject Headings
(MeSH) and key words relevant to our research question. Key
words included: rumination, rumination syndrome, infant, child,
adolescent, and pediatric. Additionally, we cross-referenced
bibliographies from relevant background articles with our search
results to ensure completeness.
We included all studies published from January 1, 2000
through June 30, 2020 that were available in English. Our
study population consisted of patients aged 1–21 years of age
inclusive. Single case reports were excluded. Series reporting
treatment outcome were included only for sample sizes >5.
Articles not reporting prevalence, pathophysiology, or treatment
outcomes were not included. Letters to the editor, review articles,
book chapters, and published abstracts were excluded with
the exception that bibliographies from review articles were
assessed for additional references. Duplicates were removed
by reviewing and comparing abstracts. Remaining titles and
abstracts (N = 325) were reviewed independently by the authors
for eligibility, yielding 49 articles for full review. Data extractions
were performed independently by two reviewers (MM and SR).
After comparing results, any discrepancies were resolved. Our
search yielded 18 manuscripts related to prevalence, 8 related
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TABLE 1 | Summary of studies reporting prevalence in pediatric rumination syndrome.
First author

Country

Population
assessed

Age range

Total
population size

Diagnostic method

Prevalence

Scarpato et al. (10)

Croatia, Greece, Israel,
Italy, Jordan, Lebanon,
Macedonia, Serbia, and
Spain

General school
population

4–18 years

13,750

Rome III questionnaire
(translated QPGS); parent
report in 4–10 y.o. and
self-report in 11–18 y.o.

0.03% in 4–10
year-olds and 0.1% in
11–18 year-olds

Robin et al. (11)

United States

General population

0–18 years

1,255

Rome IV Pediatric
diagnostic Questionnaire;
parent report

1.7% in infants, 2.1%
in toddlers and 0% in
4+ year-olds

Steutel et al. (12)

Belgium, Italy, and The
Netherlands

General pediatric or
well-baby clinic
population

0–48 months

2,751

Rome III questionnaire
(QPGS); parent report

4.3% in 0–12
month-olds and 0% in
13–48 month-olds

Altamini et al. (13)

Jordan

General school
population

4–18 years

1,587

Rome III questionnaire
(QPGS Arabic version);
self-report

0.4% in 4–10
year-olds and 0.3% in
11–18 year-olds

Peralta-Palmezano
et al. (14)

Colombia

General school
population

8–17 years

864

Rome III questionnaire
(QPGS Spanish version);
self-report

0.5% RS only, 1.3%
RS and one other
FGID,.1% RS and 2 or
3 other FGID

Bouzios et al. (15)

Greece

General school
population

6–18 years

1,588

Rome III questionnaire
(QPGS Greek version);
parent report in 6–11 y.o.
and self-report in 12–18
y.o.

0.5%

Murray et al. (16)

United States, Germany,
and Switzerland

General school
population

7–13 years

1,430

Eating Disturbances in
Youth questionnaire
(EDY-Q); self-report

9.7%

Chogle et al. (17)

Colombia

Primary careclinic
population

0–4 years

1,231

Rome III questionnaire
(QPGS Spanish version);
parent report

7.2% in 1–12
month-olds, 2.7% in
13–48 month-olds

Devanarayana et al.
(18)

Sri Lanka

General population

12–16 years

427

Rome III questionnaire
(QPGS Sinhalese version);
self-report

4%

Bhatia et al. (19)

India

General school
population

10–17 years

1,115

Rome III questionnaire
(QPGS Hindi version);
self-report

0.3%

Hartmann et al. (20)

Germany

General population

7–14 years

804

Eating Disturbances in
Youth questionnaire
(EDY-Q); self-report

11.94% with
rumination behavior at
least once, 1.49%
with recurrent

Saps et al. (21)

Columbia

General school
population

8–18 years

3,567

Rome III and IV
questionnaires (QPGS
Spanish version);
self-report

0.5% per Rome IV
and 0.4% per Rome III

Sagawa et al. (22)

Japan

General school
population

10–17 years

3,976

Rome III questionnaire
(QPGS Japanese version);
self-report

0.1%

Rajindrajith et al. (23)

Sri Lanka

General school
population

10–16 years

2,163

Rome III questionnaire
(QPGS Sinhala version);
self-report

5.1%

Lewis et al. (24)

United States

General population

4–18 years

949

Rome III questionnaire
(QPGS); parent report

0%

Játiva et al. (25)

Ecuador

General school
population

8–15 years

417

Rome III questionnaire
(QPGS Spanish version);
self-report

0.7%

Helgeland et al. (26)

Norway

Pediatric outpatient
clinic population

4–15 years

152

Rome III questionnaire
(QPGS); parent report

2%

Van Tilburg et al. (27)

United States

Pediatric
gastroenterology
clinic population

4–18 years

135

Rome III questionnaire
(QPGS); parent report and
also self-report if 10 y.o. or
older

3.5% by child report,
0.8% by parent report
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clinical setting, particularly in patients with other gastrointestinal
symptoms given that rumination frequently is associated with
other FGIDs (14, 23).

In adults, impaired accommodation has been reported in <10%
(34). In an adult study utilizing a barostat to distend the
gastric fundus, patients with rumination reported increased
nausea and bloating with no difference in gastric compliance
or accommodation; however, the patients demonstrating no
accommodation reported increased pain at increased pressures
(35). Rumination patients also had increased gastric sensitivity
during gastric distension (35). This may suggest a role for
accommodation and/or visceral hypersensitivity in at least a
subset of youth with rumination.
There is a paucity of studies evaluating inflammation
in rumination syndrome. Gastrointestinal inflammation has
been implicated in other functional gastrointestinal disorders,
including functional dyspepsia, in youth (36). Specifically,
associations have been demonstrated with increased density and
activation of eosinophils and mast cells (36). Adult rumination
syndrome has been associated with an increase in duodenal
eosinophils and intraepithelial lymphocytes (37). Recently, we
found an increase in gastric antral eosinophils and mast cells, as
well as duodenal eosinophils and intraepithelial lymphocytes, in
youth with rumination syndrome (38).

Pathophysiology
It has been proposed that there may be three pathways to
development of rumination: (1) a primary pathway involving
premonitory urges (such as seen in tic disorders); (2) a
pathway secondary to ongoing pathophysiology (such as
gastroesophageal reflux); and, (3) a pathway secondary
to psychosocial mechanisms stemming from a behavioral
association which could begin in the presence of other FGIDs
(e.g., to reduce pressure and pain in the stomach) and persist as
a learned behavior in response to contextual clues (such as foods
or changes in visceral sensation) after resolution of the other
FGID (29). It is likely that there are overlapping mechanisms in
individual patients.
Utilizing antroduodenal motility studies or high-resolution
esophageal manometry (HREM) with esophageal impedance
monitoring, the physiologic changes occurring during a
rumination episode have been well-described and appear
consistent irrespective of the triggering event. Although the
intragastric pressure threshold has varied somewhat from study
to study, rumination involves strong voluntary but generally
unconscious contraction of the muscles of the abdominal wall
promoting an increase in intragastric pressure with subsequent
movement of gastric contents into the esophagus and mouth
(i.e., the “R” or retrograde wave) (30, 31). Care needs to be
taken to ensure that increases in abdominal pressure are not due
to coughing or speaking. In controls, gastroesophageal reflux
episodes are not associated with intragastric pressure increases
of this magnitude (31). In youth with rumination, a significant
portion of rumination episodes are preceded by gastroesophageal
reflux (31, 32). Utilizing HREM and impedance, Rosen and
colleagues described three distinct patterns in patients with
primary rumination (i.e., where rumination is not induced by
a reflux episode): lower esophageal sphincter (LES) relaxation
without retrograde flow before the R wave in 51%, an R wave
followed by LES relaxation in 20%, and an R wave without LES
relaxation in 29% of episodes (32).
In the absence of gastroesophageal reflux as a triggering
event, the etiology of rumination is not well-delineated,
particularly in children. Rumination is frequently associated with
other gastrointestinal symptoms or functional gastrointestinal
disorders. Concomitant abdominal pain has been reported in 23–
38%, nausea in 17–30%, and constipation in 21–23% of youth
previously diagnosed with rumination (5, 7). This might suggest
some shared pathophysiology or that other gastrointestinal
conditions may predispose to development of rumination.
Dysmotility, poor accommodation, and visceral hyperalgesia
have been described in functional dyspepsia (FD), another FGID
originating from the upper gastrointestinal tract (33). Gastric
emptying has been evaluated in youth with rumination and
delayed emptying reported in 30–46% (5, 8). Whether abnormal
studies are indicative of poor emptying or an artifact created by
frequent regurgitation is not clear. We found no studies assessing
accommodation or visceral sensitivity in youth with rumination.

Frontiers in Pediatrics | www.frontiersin.org

Treatment
Diaphragmatic breathing has emerged as the mainstay of
treatment. While open trials and randomized controlled trials of
diaphragmatic breathing have contained some older adolescents,
they are primarily studies which have been performed in adults. A
systematic review of primarily adult studies assessing rumination,
concluded that the efficacy of diaphragmatic breathing was
supported by four chart reviews, two open clinical trials (N=
28 and N= 10), and one randomized trial (N = 23) which all
demonstrated a significant decrease in daily regurgitation (29).
It is believed that the primary mode of action of diaphragmatic
breathing is that it creates a competing response to the abdominal
wall contractions that create a rumination episode (39, 40).
In adults, diaphragmatic breathing counteracts the increase
in intragastric pressure and also increases pressure at the
esophageal-gastric junction (41). While diaphragmatic breathing
results in a significant decrease in rumination episodes, for many
or most patients, rumination continues albeit at a lower rate
(39, 40, 42). Other techniques for creating competing responses
(e.g., chewing or sucking on hard candy or peppermints) have
been reported in individual patients but not studied in controlled
trials or in comparison to diaphragmatic breathing (29).
To the extent that stress is an exacerbating factor in
rumination, diaphragmatic breathing also may provide indirect
benefit by inducing a relaxation response that can further
minimize the likelihood of rumination (43). Other commonly
employed methods for addressing anxiety, such as cognitive
behavioral therapy or hypnosis, are frequently utilized as part
of multiple interventions in the treatment of rumination but
have not been evaluated individually in controlled trials for the
treatment of rumination.
As noted earlier, in a prospective study of patients in
a pediatric gastroenterology clinic, Malik and colleagues
evaluated 50 children presenting with vomiting and diagnosed
rumination syndrome in 30 (7). Seven of these self-resolved
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constipation, nausea, abdominal pain) and/or biologic factors
(e.g., inflammation, nerve sensitivity, motility issues) that may
underlie or complicate rumination, and to consider medications
to augment behavioral interventions for rumination. The role
of the mental health provider is to assess and treat co-morbid
psychological conditions that may serve a contributory role (e.g.,
anxiety, depression), improve autonomic balance and rest/digest
functions via relaxation training, and engage the patient in habit
reversal training focused on identification of effective competing
responses and the optimal timing/triggers for their use.

without treatment after the initial consultation, counseling,
and evaluation and 23 underwent education regarding the
pathophysiology of rumination and were taught diaphragmatic
breathing. Of these 23 patients, rumination resolved in 82.6%
initially, although 28.5% of these relapsed (7). In a retrospective
study of 52 children utilizing instruction in diaphragmatic
breathing, biofeedback, relaxation training, and/or cognitive
behavioral therapy, rumination resolved in 29.6%, improved in
55.6%, and was unchanged in 12.9% (5). In a group of 12
patients treated as inpatients with antidepressants, anxiolytics,
and cognitive behavioral therapy with biofeedback or relaxation
techniques, resolution or improvement was seen in 10 of 12
patients (44). In a long-term (9.5–48.5 months) follow-up study
of patients treated for rumination, 40% reported a ruminationfree period of 2 weeks−6 months and 19% a remissionfree period of >6 months (43). However, over 70% of those
with prolonged remission periods had recurrence, most often
associated with stress, illness, specific foods, or menstruation—
triggers also common for other FGIDs (43).
There have been very few studies evaluating medications
in the treatment of rumination syndrome and most involve
medication in combination with other treatment modalities.
While acid-reduction therapy or promotility agents are
frequently instituted to treat presumed gastroesophageal reflux,
clinic experience (in the absence of prospective, controlled
trials) would indicate they are not effective in rumination
(29). Certainly, if a patient with suspected gastroesophageal
reflux is not responsive to acid-reduction therapy (although
ideally earlier), rumination should be considered. In the only
prospective placebo-controlled trial we identified, Pauwels
and colleagues assessed the effects of baclofen in 20 patients,
ages 18–61 years, with suspected rumination or supra-gastric
belching (45). Baclofen resulted in a higher rate of subjective
improvement (63 vs. 26%), increased lower esophageal sphincter
pressure, decreased transient lower esophageal relaxation, and
decreased reflux episodes (45). A case series also reported
decreased rumination in 12 adults treated with baclofen (46).
These findings suggest that baclofen may be helpful in reducing
rumination, at least in part, by decreasing gastroesophageal
reflux which may induce rumination. Baclofen has been reported
to be helpful in pediatric gastroesophageal reflux as well and thus
could be considered in the treatment of rumination in children
and adolescents (47).
While some patients may experience resolution of rumination
following a basic introduction of competing responses such
as diaphragmatic breathing, a significant proportion will
continue to have on-going symptoms or experience relapse.
This is particularly true for those with co-morbid anxiety
or depression and when experiencing stress (43, 48). Most
patients will be better served by an interdisciplinary team
consisting of a medical provider, a mental health provider,
and often a dietician, particularly in the setting of weight
loss. Treatment begins with confirming the diagnosis, providing
reassurance, and educating patients on the pathophysiology of
rumination syndrome, including factors which may exacerbate
symptoms. The role of the medical provider is to assess
and treat co-morbid conditions (e.g., gastroesophageal reflux,

Frontiers in Pediatrics | www.frontiersin.org

CONCLUSIONS AND FUTURE
DIRECTIONS
Pediatric rumination syndrome remains greatly understudied
with regard to prevalence, pathophysiology, and particularly
regarding treatment. There is a need to better define prevalence
in both the primary care and subspecialty clinical settings,
especially in patients presenting with vomiting or apparent
gastroesophageal reflux. The history in these patients should
include assessment of symptoms indicative of rumination. In
patients where rumination is preceded by lower esophageal
sphincter relaxation and/or reflux, there is a need for followup studies to determine whether treatment of gastroesophageal
reflux results in resolution of rumination. Given that rumination
is often accompanied by other gastrointestinal symptoms, or
other FGIDs, and may be a compensatory mechanism learned
to control discomfort, there is a need to determine whether
treatment of co-morbid conditions results in improvement of
rumination. If the triggering event is still present (whether
stress, inflammation, gastroesophageal reflux, etc.), it may be
more difficult to effectively treat rumination and harder to gain
adherence to future repeat behavioral treatment efforts following
treatment failure. Although diaphragmatic breathing likely has
benefit for rumination syndrome, significant long-term efficacy
in youth has yet to be demonstrated with relatively high rates
of relapse and short duration of symptom-free periods. It needs
to be studied and compared to other competing responses (e.g.,
gum chewing or sucking on hard candy, particularly peppermints
as these may have additional benefits in relaxing smooth muscle
and improving accommodation). As most pediatric reports have
included multiple treatment modalities, individual components
need to be studied to understand which are effective (alone or in
combination) to increase the efficiency of care.
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Prevalence of functional gastrointestinal disorders in children and adolescents
in the Mediterranean region of Europe. Clin Gastroenterol Hepatol. (2018)
16:870–6. doi: 10.1016/j.cgh.2017.11.005
11. Robin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, et al. Prevalence
of pediatric functional gastrointestinal disorders utilizing the Rome IV
criteria. J Pediatr. (2018) 195:134–9. doi: 10.1016/j.jpeds.2017.12.012
12. Steutel NF, Zeevenhooven J, Scarpato E, Vandenplas Y, Tabbers MM, Staiano
A, et al. Prevalence of functional gastrointestinal disorders in European infants
and toddlers. J Pediatr. (2020) 221:107–14. doi: 10.1016/j.jpeds.2020.02.076
13. Altamimi E, Scarpato E, Saleh I, Tantawi K, Alassaf M, Ijam M, et al. National
prevalence of functional gastrointestinal disorders in Jordanian children. Clin
Exp Gastroenterol. (2020) 13:267–72. doi: 10.2147/CEG.S256276
14. Peralta-Palmezano JJ, Guerrero-Lozano R. Prevalence of functional disorders
in school children and adolescents. Korean J Gastroenterol. (2019) 73:207–
12. doi: 10.4166/kjg.2019.73.4.207
15. Bouzios I, Chouliaras G, Chrousos GP, Roma E, Gemou-Engesaeth V.
Functional gastrointestinal disorders in Greek children based on Rome
III criteria: identifying the child at risk. Neurogastroenterol Motil. (2017)
29:e12951. doi: 10.1111/nmo.12951
16. Murray HB, Thomas JJ, Hinz A, Munsch S, Hilbert A. Prevalence in primary
school youth of pica and rumination behavior: the understudied feeding
disorders. Int J Eat Disord. (2018) 51:994–8. doi: 10.1002/eat.22898
17. Chogle A, Velasco-Benitez CA, Koppen IJ, Moreno JE, Ramírez
Hernández CR, Saps M. A population-based study on the epidemiology
of functional disorders in young children. J Pediatr. (2016)
179:139–43.e1. doi: 10.1016/j.jpeds.2016.08.095
18. Devanarayana NM, Adhikari C, Pannala W, Rajindrajith S. Prevalence of
functional gastrointestinal diseases in a cohort of Sri Lankan adolescents:
comparison between Rome II and Rome III criteria. J Trop Pediatr. (2011)
57:34–9. doi: 10.1093/tropej/fmq039
19. Bhatia V, Deswal S, Seth S, Kapoor A, Sibal A, Gopalan S. Prevalence
of functional gastrointestinal disorders among adolescents in Delhi based
on Rome III criteria: a school-based survey. Indian J Gastroenterol. (2016)
35:294–8. doi: 10.1007/s12664-016-0680-x
20. Hartmann AS, Poulain T, Vogel M, Hiemisch A, Kiess W, Hilbert A.
Prevalence of pica and rumination behaviors in German children aged 714 and their associations with feeding, eating, and general psychopathology:

Frontiers in Pediatrics | www.frontiersin.org

22.

23.

24.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34.

35.

36.

37.

38.

6

a population-based study. Eur Child Adolesc Psychiatry. (2018) 27:1499–
508. doi: 10.1007/s00787-018-1153-9
Saps M, Velasco-Benitez CA, Langshaw AH, Ramírez-Hernández CR.
Prevalence of functional gastrointestinal disorders in children and
adolescents: comparison between Rome III and Rome IV criteria. J Pediatr.
(2018) 199:212–6. doi: 10.1016/j.jpeds.2018.03.037
Sagawa T, Okamura S, Kakizaki S, Zhang Y, Morita K, Mori M. Functional
gastrointestinal disorders in adolescents and quality of life. J Gastroenterol
Hepatol. (2013) 28:285–90. doi: 10.1111/j.1440-1746.2012.07257.x
Rajindrajith S, Devanarayana NM, Crispus Perera BJ. Rumination
syndrome in children and adolescents: a school survey assessing
prevalence
and
symptomatology.
BMC
Gastroenterol.
(2012)
12:163. doi: 10.1186/1471-230X-12-163
Lewis ML, Palsson OS, Whitehead WE, van Tilburg MAL. Prevalence of
functional gastrointestinal disorders in children and adolescents. J Pediatr.
(2016) 177:39–43.e3. doi: 10.1016/j.jpeds.2016.04.008
Játiva E, Velasco-Benítez CA, Koppen IJN, Játiva-Cabezas Z,
Saps M. Prevalence of functional gastrointestinal disorders in
schoolchildren in Ecuador. J Pediatr Gastroenterol Nutr. (2016)
63:25–8. doi: 10.1097/MPG.0000000000001108
Helgeland H, Flagstad G, Grøtta J, Vandvik PO, Kristensen H,
Markestad T. Diagnosing pediatric functional abdominal pain in
children (4-15 years old) according to Rome III criteria: results from
a Norwegian prospective study. J Pediatr Gastroenterol Hepatol. (2009)
49:309–15. doi: 10.1097/MPG.0b013e31818de3ab
van Tilburg MA, Squires M, Blois-Martin N, Leiby A, Langseder A.
Test of the child/adolescent Rome III criteria: agreement with physician
diagnosis and daily symptoms. Neurogastroenterol Motil. (2013) 25:302–
e246. doi: 10.1111/nmo.12056
Schurman JV, Friesen CA, Danda CE, Andre A, Welchert E, Lavenbarg T,
et al. Diagnosing functional abdominal pain with the Rome criteria: parent,
child, and clinician agreement. J Pediatr Gastroenterol Nutr. (2005) 41:291–
5. doi: 10.1097/01.mpg.0000178438.64675.c4
Murray HB, Juarascio AS, Di Lorenzo C, Drossman DA, Thomas JJ. Diagnosis
and treatment of rumination syndrome: a critical review. Am J Gastroenterol.
(2019) 114:562–78. doi: 10.14309/ajg.0000000000000060
Singendonk MMJ, Oors JM, Bredenoord AJ, Omari TI, van der Pol RJ, Smits
MJ, et al. Objectively diagnosing rumination syndrome in children using
esophageal pH-impedance and manometry. Neurogastroenterol Motil. (2017)
29:e12996. doi: 10.1111/nmo.12996
Grunder FR, Aspirot A, Faure C. High-resolution esophageal manometry
patterns in children and adolescents with rumination syndrome. J Pediatr
Gastroenterol Nutr. (2017) 65:627–32. doi: 10.1097/MPG.0000000000001618
Rosen R, Rodriguez L, Nurko S. Pediatric rumination subtypes: a study using
high-resolution esophageal manometry with impedance. Neurogastroenterol
Motil. (2017) 29:e12998. doi: 10.1111/nmo.12998
Rosen JM, Cocjin JT, Schurman JV, Colombo JM, Friesen CA. Visceral
hypersensitivity and electromechanical dysfunction as therapeutic targets in
pediatric functional dyspepsia. World J Gastrointest Pharmacol Ther. (2014)
5:122–38. doi: 10.4292/wjgpt.v5.i3.122
Bredenoord AJ, Chial HJ, Camilleri M, Mullan BP, Murray JA. Gastric
accommodation and emptying in evaluation of patients with upper
gastrointestinal symptoms. Clin Gastroenterol Hepatol. (2003) 1:264–72.
Thumshirn M, Camilleri M, Hanson RB, Williams DE, Schei
AJ, Kammer PP. Gastric mechanosensory and lower esophageal
sphincter function in rumination syndrome. Am J Physiol. (1998)
275:G314–21. doi: 10.1152/ajpgi.1998.275.2.G314
Friesen CA, Schurman JV, Colombo JM, Abdel-Rahman SM. Eosinophils and
mast cells as therapeutic targets in pediatric functional dyspepsia. World J
Gastrointest Pharmacol Ther. (2013) 4:86–96. doi: 10.4292/wjgpt.v4.i4.86
Halland M, Talley NJ, Jones M, Murray JA, Cameron R, Walker MM.
Duodenal pathology in patients with rumination syndrome: duodenal
eosinophilia and increased intraepithelial lymphocytes. Dig Dis Sci. (2019)
64:832–7. doi: 10.1007/s10620-018-5387-7
Friesen HJ, Rosen J, Low Kapalu C, Singh M, Spaeth T, Cocjin JT,
et al. Mucosal eosinophils, mast cells, and intraepithelial lymphocytes
in youth with rumination syndrome. Neurogastroenterol Motil. (2021)
e14155. doi: 10.1111/nm0.14155

August 2021 | Volume 9 | Article 709326

Martinez et al.

Rumination Syndrome

with rumination and supragastric belching. Clin Gastroenterol Hepatol. (2012)
10:379–84. doi: 10.1016/j.cgh.2011.10.042
47. Vadlamudi NB, Hitch MC, Dimmitt RA, Thame KA. Baclofen for the
treatment of pediatric GERD. J Pediatr Gastroenterol Nutr. (2013) 57:808–
12. doi: 10.1097/MPG.0b013e3182a2747b
48. Alioto A, Yacob D, Yardley HL, Di Lorenzo C. Inpatient treatment of
rumination syndrome: outcomes and lessons learned. Clin Pract Pediatr
Psychol. (2015) 3:304–13. doi: 10.1037/cppp0000115

39. Barba E, Burri E, Accarino A, Malagelada C, Rodriguez-Urrutia A, Soldevilla
A, et al. Biofeedback-guided control of abdominothoracic muscular activity
reduces regurgitation episodes in patients with rumination. Clin Gastroenterol
Hepatol. (2015) 13:100–6.e1. doi: 10.1016/j.cgh.2014.04.018
40. Barba E, Accarino A, Soldevilla A, Malagelada JR, Azpiroz F. Randomized,
placebo-controlled trial of biofeedback for the treatment of rumination. Am J
Gastroenterol. (2016) 111:1007–13. doi: 10.1038/ajg.2016.197
41. Halland M, Parthasarathy G, Bharucha AE, Katzka DA. Diaphragmatic
breathing for rumination syndrome: efficacy and mechanisms of
action. Neurogastroenterol Motil. (2016) 28:384–91. doi: 10.1111/nmo.
12737
42. Tucker E, Knowles K, Wright J, Fox MR. Rumination variations: aetiology
and classification of abnormal behavioural responses to digestive symptoms
based on high-resolution manometry studies. Aliment Pharmacol Ther. (2013)
37:263–74. doi: 10.1111/apt.12148
43. Alioto A, Di Lorenzo C. Long-term follow-up of adolescents treated for
rumination in an inpatient setting. J Pediatr Gastroenterol Nutr. (2018) 66:21–
5. doi: 10.1097/MPG.0000000000001632
44. Khan S, Hyman PE, Cocjin J, Di Lorenzo C. Rumination
syndrome
in
adolescents.
J
Pediatr.
(2000)
136:528–
31. doi: 10.1016/s0022-3476(00)90018-0
45. Pauwels A, Broers C, Van Houtte B, Rommel N, Vanuytsel T, Tack J.
A randomized double-blind, placebo-controlled, cross-over study using
baclofen in the treatment of rumination syndrome. Am J Gastroenterol. (2018)
113:97–104. doi: 10.1038/ajg.2017.441
46. Blondeau K, Boecxstaens V, Rommel N, Farré R, Depeyper S, Holvoet L, et al.
Baclofen improves symptoms and reduces postprandial flow events in patients

Frontiers in Pediatrics | www.frontiersin.org

Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Publisher’s Note: All claims expressed in this article are solely those of the authors
and do not necessarily represent those of their affiliated organizations, or those of
the publisher, the editors and the reviewers. Any product that may be evaluated in
this article, or claim that may be made by its manufacturer, is not guaranteed or
endorsed by the publisher.
Copyright © 2021 Martinez, Rathod, Friesen, Rosen, Friesen and Schurman. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.

7

August 2021 | Volume 9 | Article 709326

